OLCM: no
Supplied: 6mg/2ml and 12mg/4ml pre-filled syringes.
Pharmacology and actions: Adenosine is a naturally occurring nucleoside that has the ability to slow conduction through the AV node. Since most cases of PSVT involve AV nodal re-entry, adenosine is capable of interrupting the AV nodal circuit and stopping the tachycardia, restoring NSR. It is eleminated from the circulation rapidly and has a half-life in the blood of less then ten seconds.
Indications: To convert PSVT to a NSR, including PSVT that is associated with accessory bypass tracts( e.g. Wolff-Parkinson-White syndrome)>
Contraindications: A. Second or Third degree heart block. B. Sick sinus syndrome. C. Known hypersensitivity. D. Atrial fibrillation.
Precautions: A. When doses larger than 12mg are given by injection there may be a decrease in blood pressure secondary to a decrease in vascular resistance. B. The effects of adenosine are antagonized by methylxanthines such as theophylline and caffeine. Larger doses of adenosine may be required. C. Adenosine effects are protentiated by dipridamole (Persantine) resulting in prolonged asystole. D. In the pressence of carbamazepine (tegretol), high degree heart block may occour. E. Adenosine is not effective in converting atrial fibrillation, atrial flutter or ventricular tachycardia. F. All doses of adenosine should be reduced to one-half(50%) in the following clinical settings. 1. history of cardiac transplantation. 2. pt's who are on carbamazepine (tegretol) and dipyridamole (persantine).
Side effects and notes: may cause facial flushing, shortness of breath, chest pressure, nausea, headache and light headedness.
Adult dosing: PSVT- 6mg rapid IV. May repeat with 12mg IV x2 if pt fails to convert after 6mg dose. Use a large proximal IV site with fluid bolus flush.
Pediatric dosing: PSVT- 0.1 mg/kg IV. May repeat with 0.2 mg/kg once if pt fails to convert after first dose. Use a large proximal IV site with fluid bolus flush. |